Role of mRNA transcript stability in modulation of expression of the gene encoding thrombin activable fibrinolysis inhibitor
- 1 November 2004
- journal article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 2 (11) , 1969-1979
- https://doi.org/10.1111/j.1538-7836.2004.00971.x
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Thrombin-activatable fibrinolysis inhibitor and the risk for recurrent venous thromboembolismBlood, 2004
- Association between thrombin activatable fibrinolysis inhibitor genotype and levels in plasma: comparison of different assaysBritish Journal of Haematology, 2004
- Development of a Genotype 325–Specific proCPU/TAFI ELISAArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Characterization of the Gene Encoding Human TAFI (Thrombin-Activable Fibrinolysis Inhibitor; Plasma Procarboxypeptidase B)Biochemistry, 1999
- A Study of the Mechanism of Inhibition of Fibrinolysis by Activated Thrombin-activable Fibrinolysis InhibitorJournal of Biological Chemistry, 1998
- Plasma and Recombinant Thrombin-activable Fibrinolysis Inhibitor (TAFI) and Activated TAFI Compared with Respect to Glycosylation, Thrombin/Thrombomodulin-dependent Activation, Thermal Stability, and Enzymatic PropertiesPublished by Elsevier ,1998
- Hypoxia-inducible Protein Binding to Vascular Endothelial Growth Factor mRNA and Its Modulation by the von Hippel-Lindau ProteinPublished by Elsevier ,1996
- TAFI, or Plasma Procarboxypeptidase B, Couples the Coagulation and Fibrinolytic Cascades through the Thrombin-Thrombomodulin ComplexPublished by Elsevier ,1996
- Activation and Characterization of Procarboxypeptidase B from Human PlasmaBiochemistry, 1995
- Characterization of the transcription products of glyceraldehyde 3‐phosphate‐dehydrogenase gene in HeLa cellsEuropean Journal of Biochemistry, 1984